Convened the Zhejiang product conference successfully;

Chitinase 3-like protein 1(Fibro-CHI) appeared on The 27th Conference of Asian Pacific Association for the Study of the liver(India).

We acquired the price of official approval for the test items of Fibro-CHI by four provinces,including Hubei, Hunan,Tianjing and Zhejiang;

Fibro-CHI made a splashy appearance at the Conference of American for the study of the liver,on October 20th,2017;

Successfully took the lead in applying for the National Science and Technology Major Project and the Infectious Disease Prevention project;

Won a “Winning enterprise award”from the 6th China Innovation and entrepreneurship Compition;

Prof. Biaoyang Lin was offered as a visiting professor of the Third Affiliated Hospital of Sun Yat-sen University.

Established the Zhejiang Proprium Health and Precision Medicine Research Institute;

Signed a cooperation agreement with Pakistani Armed Forces Institute of Pathology;

Proprium acquires a new Chinese invention patent.

Acquired the ISO 13485 Quality System Management Certification;

Proprium acquired CE certification for the products of the Heart Disease POCT Series, the detection of Fibro-CHI in liver fibrosis and the diagnosis of the liver cancer;

Proprium acquires a new Chinese invention patent.

Obtained the product registration certificate of zhejiang food and drug administration for the products of the detection of Fibro-CHI in liver fibrosis and the diagnosis of the liver cancer;

Proprium acquires a new Chinese invention patent and two Japanese invention patents.

Proprium was recognized as a Hangzhou new high-tech enterprise;

Obtained the registered trademark for “Proprium Biotech”;

Won the provincial science and technology program for the Liver cancer dual-label detection kit;

Proprium Biotech moved to Yinhai Street, Xiasha, Hangzhou and completed the construction of GMP workshop;

Proprium Biotech obtains the Permits for Medical Device Production Enterprises.

Proprium Biotech Company was established in the Virgin Islands;

Proprium Biotech(foreign-owned) was established with a registered capital of 10 million dollars,in Hangzhou Xiasha Singapore Science and Technology Park.